イベント

すべて表示
    Join BIOCYTOGEN at Scientist.com Vendor Discovery Day – San Francisco

    Join BIOCYTOGEN at Scientist.com Vendor Discovery Day – San Francisco

    August 26, 2025
    〜でシェア:

    We are delighted to take part in Scientist.com Vendor Discovery on August 26th, at The Lighthouse Cafe & Conference Center in San Francisco, CA! We’re excited for the chance to connect with leading researchers and share our latest advancements in biotechnology. Be sure to stop by our vendor for Biocytogen’s newest innovations and get a glimpse of what’s ahead in our research. We look forward to seeing you this August!

    What is Scientist.com Vendor Discovery Day?

    Scientist.com Vendor Discovery Day is a one-day, in person event designed for R&D service providers to showcase their latest innovations. It offers a unique opportunity to engage directly in meaningful conversations, gain valuable insights, and build lasting connections. This event is ideal for connecting with researchers, innovators and potential partners, particularly within the pharmaceutical and biotechnology industries, as companies are showcasing cutting-edge solutions to the scientific research community. 

    Event Overview  

    Date: August 26th, 2025 | Time: 5:00pm-8:00pm PT

    Venue: The Lighthouse Cafe & Conference Center, 685 Gateway Blvd South San Francisco, CA, 94080

    Event Schedule

    For more information about the event, please refer to Vendor Discovery Day- San Francisco .  

    About BIOCYTOGEN

    Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

    We look forward to seeing you in San Francisco!